Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Unravelling Clinical AI: Interview with Nicholas Fuggle
4
Mins
March 2025
EMJ is delighted to introduce Nicholas Fuggle, Associate Professor in Rheumatology at the University of Southampton, UK, and co-organiser…
Read more
10
Mins
29 Jul 2019
Postmenopausal Osteoporosis: A Mini Review
Osteoporosis is a systemic skeletal disease characterised by microarchitectural deterioration and high fragility of bone tissue, resulting in low bone…
11
Mins
29 Jul 2019
Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome
Although aPL are reported in 1–5% of the general population,2 only a minority of these individuals will develop the clinical manifestations of APS. The incidence of APS…
11
Mins
29 Jul 2019
Secukinumab in the Management of Psoriatic Arthritis: Current Perspectives
Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…
8
Mins
29 Jul 2019
A Review of Adalimumab Biosimilars for the Treatment of Immune-Mediated Rheumatic Conditions
Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…
5
Mins
29 Jul 2019
Real-World Experience of Apremilast in Treating Psoriatic Arthritis Patients with Comorbidities
Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…
9
Mins
13 Dec 2018
Central Processes Underlying Fibromyalgia
Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…
9
Mins
13 Dec 2018
Drilling Down to the Bone: Evaluating Bone Marrow Lesions in Osteoarthritis
Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…
9
Mins
13 Oct 2018
Effect of Mesenchymal Stem Cells in Autoimmune Arthritis
The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…
Loading posts...
« Previous
1
…
10
11
12
13
14
…
21
Next »